Stephanie Christenson
Professor in Residence · University of California (San Francisco) School of Medicine
Credentials: · · · · ·
History
- 2009–2012
Pulmonary Disease and Critical Care Medicine
- 2002–2006
- 1998–2002
Research
Chronic obstructive pulmonary disease
Review · The Lancet · 2022 · First of 4 authors · 1,077 citations
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function
New England Journal of Medicine · 2016 · 576 citations
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
New England Journal of Medicine · 2023 · 433 citations
57 papers · 21 as a resident
40 papers
33 papers
33 papers
30 papers
27 papers
25 papers
24 papers
Grants
- 2023–2028
National Human Genome Research Institute · U01
Contact PI · $3.2M · University of California, San Francisco
- 2019–2025
Integrated Analysis of Microbial and Genomic Data in Obstructive Lung Disease (I AM GOLD) Study
National Heart, Lung, and Blood Institute · R01
PI · $1.5M · University of California, San Francisco
- 2015–2021
Identifying the Th2 Endotype in COPD: Clinical and Pathologic Implications
National Heart, Lung, and Blood Institute · K23
Contact PI · $847.4K · University of California, San Francisco
- 2014
Common Genomic Mechanisms of Disease Across Asthma and COPD
National Heart, Lung, and Blood Institute · F32
Contact PI · $39.4K · University of California, San Francisco
Clinical trials
- 2026–2031
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
Site PI · Recruiting · Phase 2
Johns Hopkins University
- 2021–2027